Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma

Adams, Hugo J A; Kwee, Thomas C

doi:https://doi.org/10.1007/s00259-016-3553-8

Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma

DSpace/Manakin Repository

Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma

Adams, Hugo J A; Kwee, Thomas C

(2017) European Journal of Nuclear Medicine and Molecular Imaging, volume 44, issue 2, pp. 342 - 343

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Letter

DOI: https://doi.org/10.1007/s00259-016-3553-8

ISSN: 1619-7070

Publisher: Springer Verlag

Note: Funding Information: This work was financially supported by an Alpe d’HuZes/Dutch Cancer Society Bas Mulder Award for T.C.K. (grant number 5409). Data collection, data analysis, and interpretation of data, writing of the paper, and decision to submit were left to the authors’ discretion and were not influenced by Alpe d’HuZes/Dutch Cancer Society.

(Peer reviewed)